AtriCure, Inc.
Company Stats
- Market Cap
- $2.9B
- as of Sep 30, 2026
- Shares Outstanding
- 50.9M
- Free Float
- 83.4%
Income Statement
- Revenue
- $534.5M
- Operating Income
- -$9.4M
- Net Income
- -$11.4M
- EBITDA
- $2.6M
- Revenue Growth, 3Y
- 17.4%
- FCF Margin, 3Y Avg
- 2.4%
- FCF Margin, Worst Year
- -1.9%
Cash Flow
- Free Cash Flow
- $48.3M
- FCF Yield
- 1.7%
- Owner FCF Yield
- 0.1%
Balance Sheet
- Cash & Equivalents
- $167.4M
Returns & Capital
- SBC, 3Y Avg
- $40.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $534.5M | $48.3M | 9.0% |
| FY2024 | $465.3M | $745,000 | 0.2% |
| FY2023 | $399.2M | -$7.5M | -1.9% |
| FY2022 | $330.4M | -$39.0M | -11.8% |
| FY2021 | $274.3M | -$23.5M | -8.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back